Results 11 to 20 of about 28,258 (196)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients

open access: yesPharmaceutics, 2022
The aim of this prospective study was to evaluate the pharmacokinetics of ganciclovir in lung transplant recipients, to explore its covariates, and to propose an individualized dosing regimen.
Eliska Dvorackova   +2 more
exaly   +4 more sources

A Case of Severe Ganciclovir-Induced Encephalopathy

open access: yesCase Reports in Neurology, 2013
Background: Ganciclovir, a drug against cytomegalovirus (CMV) infection, is generally well tolerated, but can cause neurotoxicity such as encephalopathy.
Hikaru Sakamoto   +8 more
doaj   +2 more sources

Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel? [PDF]

open access: yesOphthalmology and Eye Diseases, 2012
Herpes simplex keratitis (HSK) is a major cause of corneal blindness in the world. Following the primary infection, the virus enters into a latent phase.
Afsun Sahin, Pedram Hamrah
doaj   +2 more sources

Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report [PDF]

open access: yesBMC Ophthalmology, 2018
Background Cytomegalovirus (CMV) retinitis is an opportunistic infection that primarily affects immunocompromised individuals. Intravitreal ganciclovir injection monotherapy or in combination with systemic anti-CMV therapy are effective treatments for ...
Lawrence P. L. Iu   +3 more
doaj   +3 more sources

Reversion of Val(Ganciclovir)-Resistance-Associated Mutations in Two SOT Patients with Mismatched Serostatus for CMV (D+/R-) [PDF]

open access: yesViruses
The emergence of drug-resistant cytomegalovirus (CMV) complicates viral response to therapy. We present two cases of solid organ transplant (SOT) recipients, highlighting the reversion of UL97 mutations associated with val(ganciclovir) resistance ...
Elena Seminari   +9 more
doaj   +2 more sources

Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
AIM: To compare the effectiveness between multiple intravitreal injections of ganciclovir alone and combined with foscarnet as initial treatment for patients with newly-onset cytomegalovirus retinitis (CMVR). METHODS: The retrospective study observed 37
Jing-Jing Fan, Yong Tao, De-Kuang Hwang
doaj   +2 more sources

Long Term Therapy of Cytomegalovirus Retinitis with Ganciclovir in a Child with Acquired Immunodeficiency Syndrome

open access: yesCanadian Journal of Infectious Diseases, 1993
Cytomegalovirus retinitis is the most severe ophthalmological complication of patients with acquired immune deficiency syndrome (aids). Ganciclovir must be given continuously to control progression of the disease or relapse typically occurs.
Scott A Halperin, G Robert La Roche
doaj   +2 more sources

Topical ganciclovir in the treatment of acute herpetic keratitis

open access: yesClinical Ophthalmology, 2010
Khalid F Tabbara1,2,3, Noorjehan Al Balushi11The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, 2Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Kingdom of Saudi Arabia; 3The Wilmer ...
Khalid F Tabbara, Noorjehan Al Balushi
doaj   +1 more source

Crystallization after intravitreal ganciclovir injection

open access: yesClinical Ophthalmology, 2010
Pitipol Choopong, Nattaporn Tesavibul, Nattawut RodanantDepartment of Ophthalmology, Siriraj Hospital, Mahidol University, Bangkok, ThailandPurpose: To report crystal formation as a complication of intravitreal ganciclovir injection.Patients and methods:
Pitipol Choopong   +2 more
doaj   +1 more source

Ganciclovir use evaluation in kidney transplantation departments

open access: yesJournal of Research in Pharmacy Practice, 2016
Objective: In this study, we evaluated certain aspects of the usage and administration of one lifesaving, high-cost medication, i.e., Ganciclovir for the prevention and treatment of cytomegalovirus (CMV) infection in transplant patients.
Maryam Mozaffar   +2 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy